Ningbo Menovo Pharmaceutical Co., Ltd.SSE: 603538

Announcement on the Subsidiary Re-certified as High-tech Enterprise

Jan 23, 2026 · Issued by Ningbo Menovo Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 23, 2026 · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-the-subsidiary-re-certified-as-high-tech-enterprise

Release

Announcement on the Subsidiary Re-certified as High-tech Enterprise

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Ningbo Menovo Pharmaceutical Co., Ltd. on 6ix

Earlier from Ningbo Menovo Pharmaceutical

Notice on Convening the 1st Extraordinary General Meeting in 2026Jan 17
Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Adempas Riociguat TabletsJan 13
Indicative Announcement on the Expected Meeting of Conditions for Downward Correction of Conversion Price for "Menovo Convertible Bonds"Jan 10
in 2026Jan 8
Announcement on Self-exercise Results of Initially Granted Portion in the 3rd Exercise Period of the 2021 Stock Option Incentive and Restricted Stock Plan and Share ChangesDec 31, 2025

Later from Ningbo Menovo Pharmaceutical

Announcement on Expected Increase in Performance for 2025Jan 27
Announcement on the Holding Subsidiary Re-certified as High-tech EnterpriseJan 30
Announcement on Relocation of Company Office PremisesJan 31
Announcement on Not Revising the Downward Conversion Price of "Menovo Convertible Bonds"Feb 3
Announcement on the Implementation of Repurchase and Cancellation of Equity Incentive Restricted StocksFeb 10

All Ningbo Menovo Pharmaceutical news releases

Follow Ningbo Menovo Pharmaceutical into a list and get an email when it puts out news.

Follow Ningbo Menovo Pharmaceutical